22875087|t|Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features.
22875087|a|OBJECTIVE: To describe the phenotype of patients with C9FTD/ALS (C9ORF72) hexanucleotide repeat expansion. METHODS: A total of 648 patients with frontotemporal dementia (FTD)-related clinical diagnoses and Alzheimer disease (AD) dementia were tested for C9ORF72 expansion and 31 carried expanded repeats (C9+). Clinical and neuroimaging data were compared between C9+ (15 behavioral variant FTD [bvFTD], 11 FTD-motor neuron disease [MND], 5 amyotrophic lateral sclerosis [ALS]) and sporadic noncarriers (48 bvFTD, 19 FTD-MND, 6 ALS). RESULTS: All C9+ patients displayed clinical syndromes of bvFTD, ALS, or FTD-MND. At first evaluation, C9+ bvFTD patients had more delusions and greater impairment of working memory, but milder eating dysregulation compared to bvFTD noncarriers. C9+FTD-MND patients had a trend for longer survival and had an earlier age at onset than FTD-MND noncarriers. Voxel-based morphometry demonstrated more thalamic atrophy in FTD and FTD-MND carriers than in noncarriers. CONCLUSIONS: Patients with the C9ORF72 hexanucleotide repeat expansion develop bvFTD, ALS, or FTD-MND with similar clinical and imaging features to sporadic cases. Other FTD spectrum diagnoses and AD dementia appear rare or absent among C9+ individuals. Longer survival in C9+ FTD-MND suggests slower disease progression and thalamic atrophy represents a novel and unexpected feature.
22875087	0	23	Frontotemporal dementia	Disease	MESH:D057180
22875087	31	38	C9ORF72	Gene	203228
22875087	121	129	patients	Species	9606
22875087	135	140	C9FTD	Disease	
22875087	141	144	ALS	Disease	MESH:D008113
22875087	146	153	C9ORF72	Gene	203228
22875087	212	220	patients	Species	9606
22875087	226	249	frontotemporal dementia	Disease	MESH:D057180
22875087	251	254	FTD	Disease	MESH:D057180
22875087	287	306	Alzheimer disease (	Disease	MESH:D000544
22875087	306	318	AD) dementia	Disease	MESH:D000544
22875087	335	342	C9ORF72	Gene	203228
22875087	472	475	FTD	Disease	MESH:D057180
22875087	477	482	bvFTD	Disease	
22875087	488	491	FTD	Disease	MESH:D057180
22875087	492	512	motor neuron disease	Disease	MESH:D016472
22875087	514	517	MND	Disease	
22875087	522	551	amyotrophic lateral sclerosis	Disease	MESH:D000690
22875087	553	556	ALS	Disease	MESH:D008113
22875087	588	593	bvFTD	Disease	
22875087	598	605	FTD-MND	Disease	MESH:D057180
22875087	609	612	ALS	Disease	MESH:D008113
22875087	632	640	patients	Species	9606
22875087	673	678	bvFTD	Disease	
22875087	680	683	ALS	Disease	MESH:D008113
22875087	688	695	FTD-MND	Disease	MESH:D057180
22875087	722	727	bvFTD	Disease	
22875087	728	736	patients	Species	9606
22875087	746	755	delusions	Disease	MESH:D063726
22875087	768	796	impairment of working memory	Disease	MESH:D008569
22875087	809	829	eating dysregulation	Disease	MESH:D001068
22875087	842	847	bvFTD	Disease	
22875087	861	871	C9+FTD-MND	Disease	MESH:D057180
22875087	872	880	patients	Species	9606
22875087	950	957	FTD-MND	Disease	MESH:D057180
22875087	1013	1029	thalamic atrophy	Disease	MESH:D013786
22875087	1033	1036	FTD	Disease	MESH:D057180
22875087	1041	1048	FTD-MND	Disease	MESH:D057180
22875087	1092	1100	Patients	Species	9606
22875087	1110	1117	C9ORF72	Gene	203228
22875087	1158	1163	bvFTD	Disease	
22875087	1165	1168	ALS	Disease	MESH:D008113
22875087	1173	1180	FTD-MND	Disease	MESH:D057180
22875087	1249	1252	FTD	Disease	MESH:D057180
22875087	1276	1287	AD dementia	Disease	MESH:D000544
22875087	1352	1363	C9+ FTD-MND	Disease	MESH:D057180
22875087	1404	1420	thalamic atrophy	Disease	MESH:D013786
22875087	Association	MESH:D000690	203228
22875087	Association	MESH:D000544	203228
22875087	Association	MESH:D008113	203228
22875087	Association	MESH:D057180	203228

